Overview
MedGenome’s comprehensive testing portfolio enables clinicians to identify genetic variations that may influence drug response, efficacy and toxicity, supporting safer and more effective treatment selection. With a focus on precision, clinical relevance and evidence-based testing, our pharmacogenomics solutions help optimize therapy and improve patient care.
Pre-treatment Pharmacogenetic Screening for Carbamazepine, Oxcarbazepine & Phenytoin
Know the Genotype. Reduce Thiopurine Toxicity
Largest CAP-Accredited and NABL-Certified Genomics Sequencing Lab in South Asia
Largest CAP-Accredited and NABL-Certified Genomics Sequencing Lab in South Asia
6,00,000+ Exomes and Genomes Sequenced
Trusted by the Scientific Community, Over 1,000+ Research Citations and Counting
1,300+ Genetic Tests Across Various Disease Categories
1300+ Employees, 160+ Scientists, 150+ Genome Analysts & 70+ Bioinformatics Engineers
Delivering Excellence in 600+ Locations Pan India and Across 50 Countries.
Connect with Our Experts